Journal
Molecular therapy
Publication Date
2-3-2021
Volume
29
Issue
2
First Page
691
Last Page
701
Document Type
Open Access Publication
DOI
10.1016/j.ymthe.2020.12.031
Rights and Permissions
Li Y, Miller CA, Shea LK, Jiang X, Guzman MA, Chandler RJ, Ramakrishnan SM, Smith SN, Venditti CP, Vogler CA, Ory DS, Ley TJ, Sands MS. Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease. Mol Ther. 2021 Feb 3;29(2):691-701. doi: 10.1016/j.ymthe.2020.12.031. © 2020 The American Society of Gene and Cell Therapy. User License Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Recommended Citation
Li, Yedda; Miller, Christopher A; Shea, Lauren K; Jiang, Xuntian; Guzman, Miguel A; Chandler, Randy J; Ramakrishnan, Sai M; Smith, Stephanie N; Venditti, Charles P; Vogler, Carole A; Ory, Daniel S; Ley, Timothy J; and Sands, Mark S, "Enhanced efficacy and increased long-term toxicity of CNS-directed, AAV-based combination therapy for Krabbe disease." Molecular therapy. 29, 2. 691 - 701. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/11427
